Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding

J Clin Endocrinol Metab. 2001 Oct;86(10):4943-50. doi: 10.1210/jcem.86.10.7936.

Abstract

The N-terminal domain is conserved in all members of the IGF-binding protein superfamily. Most recently, studies have demonstrated the importance of an IGF-binding protein N-terminal hydrophobic pocket for IGF binding. To examine more critically the amino acids important for IGF binding within the full-length IGF-binding protein-3 protein while minimizing changes in the tertiary structure, we targeted residues I56, L80, and L81 within the proposed hydrophobic pocket for mutation. With a single change at these sites to the nonconserved glycine there was a notable decrease in binding. A greater reduction was seen when both L80 and L81 were substituted with glycine, and complete loss of affinity for IGF-I and IGF-II occurred when all three targeted amino acids were changed to glycine. Furthermore, the ability of the IGF-binding protein-3 mutants to inhibit IGF-I-stimulated phosphorylation of its receptor was a reflection of their affinity for IGF, with the lowest affinity mutants having the least inhibitory effect. These studies, thus, support the hypothesis that an N-terminal hydrophobic pocket is the primary site of high affinity binding of IGF to IGF-binding protein-3. The mutants provide a tool for future studies directed at IGF-dependent and IGF-independent actions of IGF-binding protein-3.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Baculoviridae / genetics
  • Binding Sites
  • COS Cells
  • Insulin-Like Growth Factor Binding Protein 3 / chemistry*
  • Insulin-Like Growth Factor Binding Protein 3 / metabolism
  • Molecular Sequence Data
  • Mutation
  • Phosphorylation
  • Receptor, IGF Type 1 / metabolism
  • Recombinant Fusion Proteins / metabolism
  • Somatomedins / metabolism*

Substances

  • Insulin-Like Growth Factor Binding Protein 3
  • Recombinant Fusion Proteins
  • Somatomedins
  • Receptor, IGF Type 1